Medical Marijuana Market Analysis By Recent Trends, Development | Industry Growth By Regions To 2026

The Global Medical Marijuana Market is forecast to reach USD 148.35 Billion by 2026, according to a new report by Reports and Data.  Marijuana is used for treating chronic pain that affects millions of people each year across the globe, thus increasing the demand for the product as a treatment procedure for medical conditions. Statistically, around 25 million people endure acute pain in the US. Moreover, several countries around the globe have made medical marijuana legal, i.e., it would allow people to use marijuana for health purposes; therefore, boosting the market for the medical marijuana market.

Side effects of the products include dizziness, fatigue, speech problem, constipation, and insomnia will hamper the growth of the market. Additionally, lack of data safety and problem in undertaking medical marijuana business is also estimated to hinder the growth of the market.

North America dominates the market of medical marijuana. The major contributors are the US and Canada. Many states in the U.S. have permitted the application of medical marijuana. Moreover, the growing number of research studies in the US, encouraging and supporting marijuana's use for medical purposes will supplement the North American medical marijuana market growth.

In 2017, Oxford University went into a partnership with Kingsley Capital Partners, for the development of cannabis treatment for inflammatory and cancer diseases. These partnerships are expected to have a positive impact on the market of medical marijuana.

To identify the key trends in the industry, click on the link below:

 https://www.reportsanddata.com/report-detail/medical-marijuana-market

Further key findings from the report suggest

• Countries are beginning to liberalize laws related to medical marijuana; the market is forecasted to witness a surge in demand. Statistically, the majority of the cannabis, are currently, sold through illicit channels.
• Several countries have recognized the advantages of this product and are in the process of legalizing it.
• With a rise in the volume of clinical trials and scientific studies, the demand for cannabis for clinical use is forecasted to grow over the forecast period. Medical marijuana held a market share of 53% in the year 2018.
• Countries in North America have also started promoting derivatives such as oils, tinctures, and resins, along with products like vaporizers, among millennial’s who are considered primary consumers.
• The oil segment is forecasted to grow with the highest CAGR of 27.1% in the forecast period. Hemp oil is in high demand among healthcare sector for clinical purposes.
• Health concerns associated with smoking is another factor that stops doctors from prescribing it. Hence, oil or edible forms of marijuana are generally prescribed and are growing in demand.
• On the basis of application, the market is segmented into Chronic Pain, Mental Disorders, Anorexia, Seizures, Muscle Spasm, Cancer, and Others.
• Chronic pain dominated the market, with a share of 63% in the year 2018. Marijuana reduced pain and also improved the quality of life among patients.
• On the basis of the route of administration, inhalation segment is forecasted to have the highest market share of 54% in the year 2026.
• Inhalation provides an advantage of controlled dosage and effective absorption of cannabinoids into the body. This should increase the demand for inhalation marijuana over the coming years.
• Key participants Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, Insys Therapeutics, Inc., MedReleaf Corporation, and GW Pharmaceuticals PLC.

Request for FREE Sample Copy of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/1413

For the purpose of this report, Reports and Data have segmented the global Medical Marijuana Market on the basis of Product Type, Route of Administration, Distribution Channel, Medical Application, and Region:

Product Type Outlook (Revenue, USD Billion; 2016-2026)

• Oil
• Buds
• Tinctures

Medical Application Outlook (Revenue, USD Billion; 2016-2026)

• Chronic Pain
• Mental Disorders
• Anorexia
• Seizures
• Muscle Spasm
• Cancer
• Others

Route of Administration Outlook (Revenue, USD Billion; 2016-2026)

• Inhalation
• Oral
• Intravenous
• Topical

Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)

• Dispensaries
• Online

Regional Outlook (Revenue, USD Billion; 2016-2026)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• The Netherlands
• Croatia
• Switzerland
• Czech Republic
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Argentina
• Colombia
• Rest of Latin America

Make an Inquiry at: https://www.reportsanddata.com/make-enquiry-form/1413

eClinical Solutions Market Dynamics, Types, Applications And Forecast To 2026

According to the current analysis of Reports and Data, the global eClinical Solutions market was valued at USD 4,267.6 Million in 2018 and is expected to reach USD 12,329.2 Million by the year 2026, at a CAGR of 13.9% from 2019-2026.

Clinical trials are the most time-consuming phase of drug development. The increasing demand for clinical trials by pharmaceutical giants and biotech companies propels the eClinical Solutions market growth. eClinical Solutions provide administrations to an enormous client base at a low working expense. Additionally, they help with tracking of information from different geographic areas, arranging, and execution of this information and drive the procedure of clinical advancement. E-clinical solutions are advantageous to reduce the time spent on assembling and analyzing data in clinical trials

Rise in appropriation of software solutions in eClinical research in trials offer various potential in clinical development processes. It can help in lowering the cost and reducing the time between development phase by identification of failing compounds. Moreover, it also offers data standardization and fast retrieval of data, which is beneficial in making quick decisions at every stage of development.

Key market players in the eClinical Solutions market are adopting strategies such as product development, partnerships, mergers, and acquisitions to maintain their position in the market. For instance, Oracle solutions offer eClinical software as a service platform solution for core administrations. In 2018, Medidata and eClinical Solutions LLC expanded their technology partnership to improve clinical trial processes.

To identify the key trends in the industry, click on the link below: 

https://www.reportsanddata.com/report-detail/eclinical-solutions-market

Further key findings from the report suggest

• CDMS led the product segment in 2018 with 27% eClinical solutions market share owing to various benefits provided by the product such as end-to-end management of various databases, clinical trial activities and real-time status tracking, which in total improves the general effectiveness of clinical trials.
• eClinical Solution system, especially, the Cloud-based delivery system is expected to grow at the CAGR of 14.8% owing to ease of integration and rapid deployment.
• Increasing clinical research in developing countries such as India, Bangladesh is expected to support the growth of eClinical Solutions market during the forecast years.
• Increasing Research and development by pharmaceuticals and biotechnology companies, resulting in the launch of new products are some of the factors that support the eClinical solutions market growth during forecast years. For Instance, in 2018, Oracle a new holistic, unified cloud-based eClinical solution, Clinical One Platform with the intention of launching new drugs in the market with a focus on quality and safety.
• Key participants in the eClinical solutions market include Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica, CRF Health, DATATRAK International, ERT, eClinical Solutions

Request For FREE Sample Copy of this Research Report at: https://www.reportsanddata.com/sample-enquiry-form/1847

For the purpose of this report, Reports and Data has segmented the eClinical solutions market on the basis of product, development phase, mode of delivery, end use, and region:

Product (Revenue, USD Million; 2016–2026)

• Electronic Clinical Outcome Assessment (ECOA)
• Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
• Clinical Analytics Platforms
• Clinical Data Integration Platforms
• Safety Solutions
• Clinical Trial Management Systems (CTMS)
• Randomization and Trial Supply Management (RTSM)
• Electronic Trial Master File (eTMF)

Development Phase (Revenue, USD Million; 2016–2026)

• Phase I
• Phase II
• Phase III
• Phase IV

Mode of Delivery (Revenue, USD Million; 2016–2026)

• Web Hosted
• Licensed Enterprise
• Cloud-based

End Use (Revenue, USD Million; 2016–2026)

• Hospitals
• Contract Research Organizations (CROs)
• Academic Institutes
• Pharmaceuticals & Biotech Organizations
• Medical Device Manufacturers

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt
• Qatar
• Latin America
• Brazil
• Argentina
• Chile

Make an Inquiry at: https://www.reportsanddata.com/make-enquiry-form/1847

Left Ventricular Assist Device (LVAD) Market Soaring at 11.3% CAGR to Reach $ 2.32 Billion by 2026

Changing lifestyle, rise in geriatric population, and technological advancements in the healthcare sector are some of the factors boosting Left ventricular assist device (LVAD) Market. 

Market Size – USD 1.06 Billion in 2018, Market Growth - CAGR of 11.3%, Market Trends –Technological advancements in the healthcare sector.

The Global Left ventricular assist device (LVAD) Market is forecast to reach USD 2.32 Billion by 2026, according to a new report by Reports and Data.

Various factors drive the growth of the LVAD market. Change in lifestyle has been one of the essential elements that have resulted in boosting the growth of this sector. It is because of changing lifestyle, individuals are exposed to habits like smoking and alcohol consumption. It is because of association with these habits, individuals have become more prone to cardiovascular disease that has resulted in increased demand for LVAD.  With changing lifestyle, dietary habits of individuals are also changing, which is leading to an increased rate of obesity. Obesity is one of the underlying reason for cardiovascular diseases. Across the globe, more than 3 billion individuals are affected by obesity. With such a rise in the rate of obesity, there has been an increase in the demand for cardiovascular care, which in turn has resulted in promoting the LVAD market.   

Check out the Sample Report here: https://www.reportsanddata.com/sample-enquiry-form/1477

Left Ventricular Assist Device (LVAD) Market 

In addition to that, developments in the healthcare sector have resulted in a rise in the geriatric population. This section of the population is highly prone to cardiovascular diseases, which has resulted in an increased demand for cardiovascular care. Such a rise in demand for cardiovascular care has a positive impact on the market growth of the industry. Apart from that, cardiovascular diseases require continuous support, and, an increase of such conditions have increased the burden on care providing organizations. To cope up with such an increased burden and to ensure a quality life for care users, LVAD has become an indispensable part of cardiac care. Each year, 18 million deaths occur across the globe due to cardiovascular diseases. Such high death rate associated with cardiovascular diseases have promoted increased investment in the healthcare sector to minimize the number of deaths related to the condition which also has a positive impact on the growth rate of the market.

In regards to region, North America can be seen to dominate the market that is primarily due to the high occurence rate of cardiovascular diseases, rise in geriatric population and rise in investments in the healthcare sector in this region.

Further key findings from the report suggest

• The Left ventricular assist device (LVAD) market held a market share of USD 1.06 Billion in the year 2018 and is forecasted to witness a CAGR of 11.3% during the forecast period.
• Changing lifestyle, rise in geriatric population, and increased investment in the healthcare sector are some of the factors that have resulted in boosting the growth of the market.
• In context to type, Implantable LVAD can be seen to occupy the largest market share. In the year 2018, it generated a higher revenue of USD 0.64 Billion with a growth rate of 11.7% during the forecast period. The fact that cardiovascular conditions require continuous support and Implantable LVAD is useful in providing long term solutions have contributed to its market revenue.
• Geriatric population is highly susceptible to cardiovascular diseases. In regards to Age group, 60-79 years segment can be seen to occupy the largest market share that generated USD 0.50 Billion in 2018 with a growth rate of 11.6% during the forecast period.
• In context to Pump type, the highest revenue can be seen to be generated by Continuous Centrifugal Pumps segment that yielded USD 0.95 Billion in the year 2018 with the highest growth rate of 11.9%. The fact that this type of pump is associated with features like long durability, simple placement process through surgery and minimal risk of thrombosis as compared to other types of pump have resulted in this segment to generate the highest revenue.
• In the application segment, Bridge-to-Recovery (BTR) Therapy can be seen to occupy the largest market share that generated the highest revenue of USD 0.35 Billion in 2018 with a CAGR of 12.1% during the forecast period. The rise in the occurrence rate of traumatic cardiac failure and the associated need for continuous cardiac support has resulted in this segment to dominate the market.
• In the end-user segment, hospitals yielded the highest revenue of USD 0.64 Billion in 2018 with a CAGR of 11.5% during the forecast period. The requirement of providing care services to various health conditions that require cardiac support have resulted in this segment to dominate the market.  

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/left-ventricular-assist-device-lvad-market

• North America holds the largest market share that generated the highest revenue of USD 35 Billion in 2018, with a CAGR of 11.7% during the forecast period. Factors like high occurrence rate of cardiovascular disease, availability of advanced technology, and rise in the geriatric population have contributed to the market share of this region.
• Key participants Sunshine Heart, CorWave, Apaxis Inc., Sun Medical Technology Research, Evaheart, Abiomed, HeartWare International, Jarvik Heart, HeartWare International, Reliantheart, Transonic, Thoratec, Terumo.

For the purpose of this report, according to Type, Age group, Pump type, Application, End-user, and Region:

Type Outlook (Revenue, USD Billion; 2016-2026)

• Transcutaneous LVAD
• Implantable LVAD

Age group Type Outlook (Revenue, USD Billion; 2016-2026)

• 20-39 years
• 40-59 years
• 60-79 years

Pump type Outlook (Revenue, USD Billion; 2016-2026)

• Pulsatile volume-displacement pumps
• First-Generation Devices
• Axial flow pumps
• Second-Generation Devices
• Continuous flow centrifugal pumps
• Third-Generation Devices

Application Type Outlook (Revenue, USD Billion; 2016-2026)

• Bridge-to-Recovery (BTR) Therapy
• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-Candidacy (BTC) Therapy

End-user Outlook (Revenue, USD Billion; 2016-2026)

• Cardiology Centers
• Hospitals

Regional Outlook (Revenue, USD Billion; 2016-2026)

• North America
  • U.S.
• Europe
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• MEA
• Latin America
  • Brazil

Go For Interesting Discount Here: https://www.reportsanddata.com/discount-enquiry-form/1477

Reasons for Buying Left Ventricular Assist Device (LVAD) Market Report:

A. The report performs an analysis of the dynamic competitive landscape that can help the reader/client move ahead in the global sector.

B. It also presents an in-depth view of the different factors driving or restraining the growth of the global market.

C. The Global Left Ventricular Assist Device (LVAD) Market report provides an eight-year forecast derived on the basis of the potential growth of the market.

D. It helps formulate profitable business decisions by offering thorough insights into the global market and by creating a comprehensive analysis of pivotal market segments and sub-segments.

Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions like Asia, United States, Europe, etc.

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com

Pharmaceutical Processing Seals Market To Reach USD 2.78 Billion By 2026

The global pharmaceutical processing seals market is forecast to reach USD 2.78 Billion by 2026, according to a new report by Reports and Data. The standard for pharmaceutical processing seals is quite high, owing to the demand for cleanliness and hygiene. Strict legal guidelines and purity requirements always need to be implemented.

Seals come in direct contact with a different variety of media at fluctuating pressures and temperatures; thus, they must be completely free of hazards and side effects. Not only should they unfailingly prevent process changes or product contamination, but they must also not impair any active agents through interactions or the transfer of sealing components.

North America held a market share of 31.5% in the year 2018. Huge consumption and high demand for innovative and new pharmaceutical drugs owing to the established healthcare companies are boosting the market growth in the region. Rising consumption of pharmaceutical manufacturing equipment in turn is expected to propel the market for pharmaceutical processing seals in the region.

To identify the key trends in the industry, click on the link below: 

https://www.reportsanddata.com/report-detail/pharmaceutical-processing-seals-market

Further key findings from the report suggest

• O-Rings held a market share of 34.2% in the year 2018. It offers the designer an efficient and economical sealing element for a wide range of dynamic applications. The production methods of these rings are inexpensive, and the ease of application makes it the most commonly used processing seal.
• Manufacturing equipment is forecasted to grow with a CAGR of 5.9% during the forecast period. These equipment are used in the pharmaceutical industry for the production of pharmaceutical compounds. Growth of the healthcare industry due to the rising population and growing incidences of chronic diseases and rising expenditure in healthcare are increasing the demand for manufacturing equipment.
• Metals are generally used for pharmaceutical processing due to their ability to withstand extreme temperature and pressure, chemical reactions, non-reactiveness from process fluids. They are also resistant to toxic chemicals and prevent contamination and leakage. Metals held the largest market share of 25.6% in the year 2018.
• Asia Pacific is forecasted to grow with a CAGR of 6.0% during the forecast period. The growing healthcare sector, coupled with high demand for over the counter drugs, are driving the market in the region. Favorable rules and regulations by the governments in the Asia Pacific region have also encouraged market growth.
• Key participants Saint-Gobain, Flowserve Corporation, Garlock, Idex Corporation, Techno Ad Ltd., Trelleborg, Parker Hannifin Corporation, Morgan Advanced Materials, Marco Rubber & Plastic Products Inc., and Technetics Group, among others.

For the purpose of this report, Reports and Data have segmented into the global Pharmaceutical Processing Seals market on the basis of type, material, application, and region:

Download FREE PDF Sample Copy of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/1840

Type Outlook (Volume: Kilo Tons; Revenue: USD Billion; 2016-2026)

• O-Rings
• Gaskets
• Lip Seals
• D Seals
• Others

Material Outlook (Volume: Kilo Tons; Revenue: USD Billion; 2016-2026)

• Metals
• PTFE
• Silicone
• Nitrile Rubber
• EPDM
• Others

Application Outlook (Volume: Kilo Tons; Revenue: USD Billion; 2016-2026)

• Manufacturing Equipment
• Others

Regional Outlook (Volume: Kilo Tons; Revenue: USD Billion; 2016-2026)

• North America
• U.S.
• Europe
• UK
• France
• Asia Pacific
• China
• India
• Japan
• MEA
• Latin America
• Brazil

Make an Inquiry at: https://www.reportsanddata.com/make-enquiry-form/1840

Diabetic Retinopathy Market Is Expected To Reach USD 13.04 Billion By 2026 | Reports and Data

Market Size – USD 7.39 billion in 2018, Market Growth – CAGR of 7.3%, Market Trends – Product Launches and Research for Advanced Tech Developments

Based on current analysis, the global diabetic retinopathy market was valued at USD 7.39 billion in 2018 and is expected to reach USD 13.04 billion by 2026, at a CAGR of 7.3%. Diabetic retinopathy is a diabetes obstacle that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). Diabetic retinopathy usually affects both the eyes. As the condition progresses, diabetic retinopathy symptoms typically include; spots or dark strings floating in your vision (floaters)blurred vision, fluctuating vision, impaired color vision, dark or empty areas in your vision and also vision loss. Diabetic retinopathy damages the blood vessels within the retinal tissue, causing them to leak fluid and distort vision. Excess of sugar intake in blood can lead to the blockage of the tiny blood vessels that nourish the retina, cutting off its blood supply. As a result, the eye attempts to grow new blood vessels nonetheless these new blood vessels don't mature properly and can leak easily. There are two types of diabetic retinopathy viz, early diabetic retinopathy and advanced diabetic retinopathy.

Get a sample copy of this premium report @ https://www.reportsanddata.com/sample-enquiry-form/1484 

Diabetic Retinopathy Market

The line of treatment for diabetic retinopathy depends exclusively on extremity of the condition and may require intraocular injections, anti-VEGF drugs, laser surgery or vitrectomy. Growing incidence of diabetes along with rising incidence of blindness because of diabetes is predicted to drive the market growth during the forecast period. Moreover, increase in purchasing power and the dread of losing vision have augmented the expenditure by patients to avail the indispensable treatment. Availability of advanced technology and minimal pain inducing laser procedure topped with quick recovery is likely to promote patients’ inclination to adopt surgical treatments. North American section accounted for the largest share of 36.8% due to the supportive compensation strategies, and increasing prevalence of diabetes.

Key findings from the report

• Asia-Pacific regional segment of the diabetic retinopathy market is expected to register itself as highest growing segment during the forecasted period, at a CAGR of 8.3%; owing it to the qualitative as well as quantitative market potential offered in developing nations such as China & India

• Non-proliferative diabetic retinopathy has registered highest CAGR of 7.5% and is successful in dominating the market with market share of 56%. The most common reason for blindness in people suffering from diabetes is non-proliferative

• According to the estimates of the screening conducted by the All India Ophthalmological Society, the prevalence of diabetic retinopathy in the data set collected by them was approximately calculated to 21.7%

• World Health Organization in 2016, estimated that 1.6 million deaths were directly caused by diabetes. WHO estimates that diabetes was the seventh leading cause of deaths

• The Diabetic Retinopathy Clinical Research Network (DRCR.net) conducts large multi-center trials to test new therapies for diabetic eye disease, and to compare different therapies. The network comprises more than 350 physicians practicing at more than 140 clinical sites across the country. They are private practice eye clinics, enabling the network to quickly bring innovative treatments from research into practice

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/diabetic-retinopathy-market

• Approximately 1.5% adults suffering from diabetes were affected from proliferative diabetic retinopathy in the U.S. in the recent past

• The EyeArt Al Eye Screening System makes in-clinic, real-time DR screening possible for any physician which enables quick and accurate identification of patients with referable DR. diabetic retinopathy screening were increased from 0 to 1000 after the implementation of EyeArt Al Eye

• Among the distribution channels, hospitals and pharmacies have accounted for the largest share in the diabetic retinopathy market. Hospitals and pharmacies comprises of well-equipped diagnosis instruments which prove to be lucrative for this segment, thus, there creating a high rate of demand in the market.

Segments covered in this market study

This report about global diabetic retinopathy market forecasts revenue growth at a global, regional and country level also, provides an analysis on the industry trends in each of the sub segments from 2016 to 2026. For the purpose of this study, the market is segmented on the basis of type, management, distribution channel and regions:

Type (Revenue in USD Million; 2016–2026)

• Proliferative diabetic retinopathy

• Non-proliferative diabetic retinopathy

• Mild

• Moderate

• Severe

Management (Revenue in USD Million; 2016–2026)

• Anti-VEGF

• Intraocular steroid injection

• Laser surgery

• Vitrectomy

Distribution channel (Revenue in USD Million; 2016–2026)

• Eye clinics

• Hospital and pharmacies

• Ambulatory surgical centers

• Other

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America

o U.S.

o Canada

• Europe

o Germany

o France

o UK

o Spain

o Italy

o Rest of the Europe

• Asia Pacific

o China

o India

o Japan

o Rest of Asia-Pacific

• Middle East & Africa

• Latin America

o Brazil

Make an inquiry before buying this report: https://www.reportsanddata.com/make-enquiry-form/1484 

The research report answers the following key questions:

• What is the growth rate of the market during the forecast period between 2019 to 2026?

• What are the crucial drivers and restraints that will impact the Diabetic Retinopathy market in the future?

• What is the market size and share speculated to be in the forecast period?

• Who are the key industry players and which executive strategies will they employ that can substantially impact the growth of the Diabetic Retinopathy market globally?

• What are the most notable trends observed in the historical data that can be expected to influence the CAGR of the Diabetic Retinopathy market?

• What are the predictions for the Diabetic Retinopathy industry in the forecast period based on the detailed analysis of its critical aspects?

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John Watson

Head of Business Development

Direct Line: +1-212-710-1370 

E-mail: sales@reportsanddata.com

Reports  and Data | Web: www.reportsanddata.com

Blood Culture Tests Market To Reach USD 7060.5 Million By 2026 | Reports and Data

Market Size – USD 3857.6 Million in 2018, Market Growth - CAGR of 8.0 %, Market Trends – Product launches and research for advanced Blood culture test

According to the current analysis of Reports and Data, the global Blood culture test market was valued at USD 3857.3 Million in 2018 and is expected to reach USD 4768.9 million by year 2026, at a CAGR of 8.0%. The study covers in depth analysis of Blood culture tests and challenges faced by them. The blood culture represents a critical tool, for the healthcare professionals as a means of identifying the harmful presence of living organisms in the bloodstream. A positive blood culture can help to find a definitive diagnosis and enable the targeting therapy against the specific organism and provide prognostic value. False positives arising due to contamination, usual risks of venipuncture increasing use central venous catheters (CVC) and other indwelling vascular access devices and high costs are major hindrance to the global blood culture test. One of the biggest challenges faced during blood sample collection is making sure an organism is inadvertently introduced in the blood. Despite its limitations, the blood culture remains the “gold standard” for the detection of bacteremia.

Get a sample copy of this premium report @ https://www.reportsanddata.com/sample-enquiry-form/1461

Blood Culture Tests Market | Reports and Data

Further key findings from the report suggest

• Blood culture tests are taken in number of suspected disease conditions which includes enteric fever, infective endocarditis, meningitis, pneumonia.
• If your blood contains Microorganism, they will utilize (eat) the nutrient available in the broth and multiply. To make sure such organisms do not die appropriate media and incubation are used. Inoculated broth is incubated in an special instrument which has controlled environment i.e. Temperature-37°C (our body temperature), aeration, agitation. After 3-5 days the instrument will give signal about the presence of organism.
• When these organisms grow in the above -mentioned media, they may make the changes in the media where they grow. Thus, lab professionals track such changes and the appearance of such organisms to identify them. Laboratory professionals use various techniques such as Gram Staining, study of morphological characteristics or Biochemical tests to identify them. Thus, finally being able to recognize which organism is present in your blood sample. Organism that cause disease to us and are frequently isolated from blood are:
• Salmonella Typhi/Para Typhi
• Staphylococcus aureus 
• Streptococcus pneumoniae
• Escherichia coli
• Acinetobacter spp
• Pseudomonas spp
• Streptococcus pyogenes 
• Enterococcus spp

• The automated blood culture technique segment is anticipated to have highest CAGR during the forecast period owing to its technological advancements, increasing investments for the launch of new products.
• Increasing demand for advanced diagnostic technologies, such as microarray, Polymerase Chain Reaction (PCR), and Peptide Nucleic Acid—Fluorescent In Situ Hybridization (PNA-FISH), is expected to propel the market growth
• North America accounts for the largest share in the global blood culture tests accounting for 35.5% of the total market share.
• Asia Pacific region is anticipated to grow at the highest CAGR because of advanced technology used in the medical sector, increasing demand for effective diagnostic techniques, various government initiatives awareness about the disease, availability of blood culture products in many regions. It accounts for 24.8% of the total market share in blood culture test.
• On the basis of product, consumables (73.3 %) are expected to hold the highest share of the blood culture test market. In comparison to instruments, consumables are a popular option.
• On the basis of technology, molecular technologies are anticipated to grow at the highest CAGR during the forecast period due to rapid increase in the incidence of sepsis.
• Key players in the blood culture market include Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, bioMérieux SA, Cepheid, Inc, Nanosphere, Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/blood-culture-tests-market

For the purpose of this study, Reports and Data have segmented the Blood culture test market on the basis of method, product, Instruments, technology, application, end use, and region:

Method (Revenue, USD Million; 2016–2026)

• Conventional/Manual Blood Culture Method
• Automated Blood Culture Method

Product (Revenue, USD Million; 2016–2026)

• Consumables  

• Blood Culture Media

• Aerobic Blood Culture Media
• Pediatric Blood Culture Media 
• Anaerobic Blood Culture Media
• Fungi/Yeast Blood Culture Media
• Mycobacteria Blood Culture Media

• Assay Kits and Reagents
• Blood Culture Accessories   

Instruments (Revenue, USD Million; 2016–2026)

• Automated Blood Culture Systems
• Supporting Laboratory Equipment

• Incubators
• Colony Counters
• Microscopes
• Gram Stainers
• Software & Services

 Technology (Revenue, USD Million; 2016–2026)

• Culture-based Technology
• Molecular Technology
• Microarray
• PCR
• PNA-FISH
• Proteomic Technology

 Application (Revenue, USD Million; 2016–2026)

• Bacteremia
• Fungemia

 End Use (Revenue, USD Million; 2016–2026)

• Hospital Laboratories
• Reference Laboratories

Make an inquiry before buying this report: https://www.reportsanddata.com/make-enquiry-form/1461

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Middle East & Africa
• Latin America
• Brazil

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com